Sana Biotechnology (SANA) shares have caught the eye lately, with investors tracking shifts in the biotech landscape and the company’s ongoing pipeline developments. There is growing interest as Sana ...

Nanjing Leads Biolabs Co., Ltd. Class H ( ($HK:9887) ) just unveiled an update. Nanjing Leads Biolabs Co., Ltd. has announced the closure of its H ...

A moratorium on artificial intelligence would weaken public oversight and freeze state protections at the very moment we need ...

After decades of failed attempts by corporate giants and research consortia across the globe, Kraig Biocraft Laboratories (OTCQB: KBLB) appears poised to crack biotechnology's most persistent ...

We've identified the following companies as similar to Global X Genomics & Biotechnology UCITS ETF USD Acc because they operate in a related industry or sector. We also considered size, growth, and ...

The U.S. Department of Health and Human Services (HHS) has canceled almost $500 million in funding for mRNA vaccine projects, alleging worries about safety and efficacy. They are winding down nearly ...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on August 5, 2025, the Compensation Committee of Puma’s Board of Directors approved ...

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...

Frontiers, one of the world's largest and fastest growing open-access publishers, announces the launch of a new journal, Frontiers in Bioengineering and Biotechnology. A broad scope journal covering ...

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Vir ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features. Reclaim your full access. Click below to renew.